Cellectis Historical Income Statement

CLLS Stock

USD 2.13 0.01 0.47%

Historical analysis of Cellectis income statement accounts such as Interest Expense of 6.7 M, Selling General Administrative of 30.4 M or Total Revenue of 717.2 K can show how well Cellectis SA performed in making a profits. Evaluating Cellectis income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Cellectis's future profits or losses.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Cellectis SA latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Cellectis SA is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cellectis SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

About Cellectis Income Statement Analysis

Cellectis SA Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Cellectis shareholders. The income statement also shows Cellectis investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Cellectis Income Statement Chart

At this time, Cellectis' Depreciation And Amortization is comparatively stable compared to the past year. Interest Expense is likely to gain to about 6.7 M in 2024, whereas Gross Profit is likely to drop slightly above 17.1 K in 2024.

Selling General Administrative Total Revenue Gross Profit Other Operating Expenses Total Operating Expenses

Total Revenue

Total revenue comprises all receipts Cellectis SA generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Cellectis SA minus its cost of goods sold. It is profit before Cellectis operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Cellectis SA. It is also known as Cellectis overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Most accounts from Cellectis' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Cellectis SA current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cellectis SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

	2021	2022	2023	2024 (projected)
Interest Expense	5.3M	3.8M	6.4M	6.7M
Depreciation And Amortization	16.6M	18.4M	18.5M	19.4M

Interest Expense Depreciation And Amortization

Cellectis income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Selling And Marketing Expenses	Research Development	Discontinued Operations	Net Income From Continuing Ops	Minority Interest	Non Recurring	Interest Income	Net Interest Income	Reconciled Depreciation
Depreciation And Amortization		0.27	-0.07	-0.08	-0.14	0.15	-0.43	-0.24	0.07	0.04	0.15	-0.48	-0.84	-0.54	-0.01	0.06	0.16	0.28	-0.21	-0.13	0.01	-0.16	-0.37	0.4
Interest Expense	0.27		0.12	0.31	-0.04	0.56	-0.44	-0.48	-0.41	0.65	0.43	-0.56	-0.35	-0.44	-0.61	-0.46	0.5	0.13	-0.6	0.32	-0.38	-0.56	-0.41	0.68
Selling General Administrative	-0.07	0.12		0.43	0.34	0.72	-0.53	-0.52	-0.56	0.39	0.72	-0.45	0.02	-0.45	-0.26	-0.19	0.47	-0.72	-0.41	0.66	-0.45	-0.3	0.54	-0.2
Total Revenue	-0.08	0.31	0.43		0.88	0.51	0.09	0.09	0.07	0.78	0.36	0.06	0.0	0.07	-0.35	-0.58	0.22	-0.39	-0.01	0.08	-0.14	-0.32	-0.15	0.04
Gross Profit	-0.14	-0.04	0.34	0.88		0.25	0.3	0.31	0.27	0.39	0.19	0.29	0.07	0.24	-0.06	-0.48	0.04	-0.4	0.27	-0.18	-0.09	-0.15	-0.12	-0.19
Other Operating Expenses	0.15	0.56	0.72	0.51	0.25		-0.79	-0.81	-0.78	0.66	0.97	-0.78	-0.15	-0.74	-0.56	-0.55	0.9	-0.44	-0.81	0.7	-0.71	-0.71	0.05	0.46
Operating Income	-0.43	-0.44	-0.53	0.09	0.3	-0.79		0.97	0.86	-0.22	-0.85	0.98	0.35	0.95	0.38	0.19	-0.85	0.21	0.88	-0.68	0.68	0.57	-0.13	-0.5
Ebit	-0.24	-0.48	-0.52	0.09	0.31	-0.81	0.97		0.95	-0.23	-0.87	0.96	0.21	0.91	0.43	0.26	-0.9	0.2	0.94	-0.71	0.76	0.63	-0.13	-0.54
Ebitda	0.07	-0.41	-0.56	0.07	0.27	-0.78	0.86	0.95		-0.22	-0.84	0.83	-0.05	0.77	0.44	0.28	-0.87	0.29	0.9	-0.76	0.79	0.6	-0.24	-0.43
Cost Of Revenue	0.04	0.65	0.39	0.78	0.39	0.66	-0.22	-0.23	-0.22		0.46	-0.26	-0.1	-0.18	-0.6	-0.5	0.38	-0.23	-0.39	0.41	-0.16	-0.43	-0.14	0.35
Total Operating Expenses	0.15	0.43	0.72	0.36	0.19	0.97	-0.85	-0.87	-0.84	0.46		-0.82	-0.13	-0.81	-0.47	-0.48	0.94	-0.45	-0.81	0.7	-0.78	-0.69	0.12	0.43
Income Before Tax	-0.48	-0.56	-0.45	0.06	0.29	-0.78	0.98	0.96	0.83	-0.26	-0.82		0.48	0.98	0.45	0.23	-0.85	0.11	0.92	-0.58	0.69	0.67	0.01	-0.61
Total Other Income Expense Net	-0.84	-0.35	0.02	0.0	0.07	-0.15	0.35	0.21	-0.05	-0.1	-0.13	0.48		0.54	0.17	-0.04	-0.14	-0.18	0.26	0.21	0.02	0.36	0.32	-0.36
Net Income	-0.54	-0.44	-0.45	0.07	0.24	-0.74	0.95	0.91	0.77	-0.18	-0.81	0.98	0.54		0.34	0.2	-0.82	0.11	0.87	-0.49	0.65	0.68	0.04	-0.58
Income Tax Expense	-0.01	-0.61	-0.26	-0.35	-0.06	-0.56	0.38	0.43	0.44	-0.6	-0.47	0.45	0.17	0.34		0.49	-0.49	0.23	0.53	-0.4	0.34	0.44	0.0	-0.34
Selling And Marketing Expenses	0.06	-0.46	-0.19	-0.58	-0.48	-0.55	0.19	0.26	0.28	-0.5	-0.48	0.23	-0.04	0.2	0.49		-0.54	-0.02	0.34	-0.18	0.5	0.64	0.36	-0.39
Research Development	0.16	0.5	0.47	0.22	0.04	0.9	-0.85	-0.9	-0.87	0.38	0.94	-0.85	-0.14	-0.82	-0.49	-0.54		-0.26	-0.88	0.62	-0.84	-0.77	-0.07	0.62
Discontinued Operations	0.28	0.13	-0.72	-0.39	-0.4	-0.44	0.21	0.2	0.29	-0.23	-0.45	0.11	-0.18	0.11	0.23	-0.02	-0.26		0.11	-0.52	0.25	0.02	-0.6	0.45
Net Income From Continuing Ops	-0.21	-0.6	-0.41	-0.01	0.27	-0.81	0.88	0.94	0.9	-0.39	-0.81	0.92	0.26	0.87	0.53	0.34	-0.88	0.11		-0.6	0.75	0.77	0.05	-0.69
Minority Interest	-0.13	0.32	0.66	0.08	-0.18	0.7	-0.68	-0.71	-0.76	0.41	0.7	-0.58	0.21	-0.49	-0.4	-0.18	0.62	-0.52	-0.6		-0.39	-0.22	0.53	0.05
Non Recurring	0.01	-0.38	-0.45	-0.14	-0.09	-0.71	0.68	0.76	0.79	-0.16	-0.78	0.69	0.02	0.65	0.34	0.5	-0.84	0.25	0.75	-0.39		0.76	0.04	-0.44
Interest Income	-0.16	-0.56	-0.3	-0.32	-0.15	-0.71	0.57	0.63	0.6	-0.43	-0.69	0.67	0.36	0.68	0.44	0.64	-0.77	0.02	0.77	-0.22	0.76		0.36	-0.66
Net Interest Income	-0.37	-0.41	0.54	-0.15	-0.12	0.05	-0.13	-0.13	-0.24	-0.14	0.12	0.01	0.32	0.04	0.0	0.36	-0.07	-0.6	0.05	0.53	0.04	0.36		-0.69
Reconciled Depreciation	0.4	0.68	-0.2	0.04	-0.19	0.46	-0.5	-0.54	-0.43	0.35	0.43	-0.61	-0.36	-0.58	-0.34	-0.39	0.62	0.45	-0.69	0.05	-0.44	-0.66	-0.69

Click cells to compare fundamentals

Cellectis Account Relationship Matchups

Cellectis income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	6.9M	9.8M	16.6M	18.4M	18.5M	19.4M
Interest Expense	2.6M	12.0M	5.3M	3.8M	6.4M	6.7M
Selling General Administrative	43.0M	44.2M	37.9M	17.5M	16.8M	30.4M
Total Revenue	12.7M	15.2M	73.9M	19.2M	755K	717.3K
Gross Profit	10.0M	3.8M	37.7M	17.4M	18K	17.1K
Other Operating Expenses	117.8M	138.7M	159.4M	108.8M	98.1M	90.0M
Operating Income	(105.1M)	(123.6M)	(85.4M)	(89.7M)	(106.6M)	(101.3M)
Ebit	(105.1M)	(123.6M)	(85.4M)	(89.7M)	(111.2M)	(105.6M)
Ebitda	(116.7M)	(75.6M)	(68.9M)	(71.2M)	(92.6M)	(88.0M)
Cost Of Revenue	2.7M	11.4M	36.3M	1.8M	737K	700.2K
Total Operating Expenses	115.1M	127.4M	123.1M	107.1M	97.3M	82.6M
Income Before Tax	(88.3M)	(115.2M)	(97.5M)	(98.6M)	(123.0M)	(116.9M)
Total Other Income Expense Net	10.5M	8.3M	(12.0M)	(8.9M)	(16.4M)	(15.6M)
Net Income	(90.7M)	(72.6M)	(86.3M)	(98.7M)	(101.1M)	(96.0M)
Income Tax Expense	(24.5M)	(24.9M)	(11.2M)	87K	(6.2M)	(6.5M)
Selling And Marketing Expenses	11.4M	1.7M	6.3M	3.1M	16.3M	8.2M
Research Development	76.6M	92.0M	87.0M	97.5M	87.6M	66.6M
Net Income From Continuing Ops	(115.2M)	(97.5M)	(125.1M)	(98.7M)	(116.8M)	(122.7M)
Net Income Applicable To Common Shares	(102.1M)	(81.1M)	(114.2M)	(106.1M)	(95.5M)	(100.3M)
Minority Interest	40.3M	33.3M	10.9M	7.9M	7.4M	7.0M
Interest Income	7.0M	1.9M	736K	1.1M	3.6M	2.9M
Net Interest Income	4.5M	(1.3M)	(4.2M)	(8.9M)	(2.8M)	(2.7M)
Reconciled Depreciation	6.9M	9.8M	16.6M	18.4M	18.5M	11.9M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Cellectis Stock Analysis

When running Cellectis' price analysis, check to measure Cellectis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectis is operating at the current time. Most of Cellectis' value examination focuses on studying past and present price action to predict the probability of Cellectis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectis' price. Additionally, you may evaluate how the addition of Cellectis to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cellectis Historical Income Statement

About Cellectis Income Statement Analysis

Cellectis Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

Total Operating Expenses

Cellectis income statement Correlations

Cellectis Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Cellectis income statement Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Cellectis Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Income Before Tax	+ 0.98	Operating Income
Net Income	+ 0.98	Income Before Tax
Total Operating Expenses	+ 0.97	Other Operating Expenses
Ebit	+ 0.97	Operating Income
Income Before Tax	+ 0.96	Ebit
Net Income	+ 0.95	Operating Income

Research Development	- 0.9	Ebit
Net Income From Continuing Ops	- 0.88	Research Development
Research Development	- 0.87	Ebitda
Total Operating Expenses	- 0.87	Ebit
Research Development	- 0.85	Income Before Tax
Research Development	- 0.85	Operating Income